Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

In situ administration of cytokine combinations induces tumor regression in mice.

EBioMedicine | 2018

Recent advances in cancer immunotherapy suggest a possibility of harnessing the immune system to defeat malignant tumors, but the complex immunosuppressive microenvironment confines the therapeutic benefits to a minority of patients with solid tumors.

Pubmed ID: 30297145 RIS Download

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Millipore (tool)

RRID:SCR_008983

An Antibody supplier

View all literature mentions

HEK293-FT (tool)

RRID:CVCL_6911

Cell line HEK293-FT is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

BALB/cAnNCrl (tool)

RRID:MGI:2683685

laboratory mouse with name BALB/cAnNCrl from MGI.

View all literature mentions

CD19 antibody [6D5] (antibody)

RRID:AB_470414

This monoclonal targets CD19 antibody [6D5]

View all literature mentions

EL4 (cell line)

RRID:CVCL_0255

Cell line EL4 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

HEK293 (cell line)

RRID:CVCL_0045

Cell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

4T1 (cell line)

RRID:CVCL_0125

Cell line 4T1 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

CT26.WT (cell line)

RRID:CVCL_7256

Cell line CT26.WT is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

LL/2 (LLC1) (cell line)

RRID:CVCL_4358

Cell line LL/2 (LLC1) is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

B16-F10 (cell line)

RRID:CVCL_0159

Cell line B16-F10 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

EL4 (cell line)

RRID:CVCL_0255

Cell line EL4 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

HEK293 (cell line)

RRID:CVCL_0045

Cell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

CD19 antibody [6D5] (antibody)

RRID:AB_470414

This monoclonal targets CD19 antibody [6D5]

View all literature mentions

4T1 (cell line)

RRID:CVCL_0125

Cell line 4T1 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

B16-F10 (cell line)

RRID:CVCL_0159

Cell line B16-F10 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

CT26.WT (cell line)

RRID:CVCL_7256

Cell line CT26.WT is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

LL/2 (LLC1) (cell line)

RRID:CVCL_4358

Cell line LL/2 (LLC1) is a Cancer cell line with a species of origin Mus musculus

View all literature mentions